retatrutide dosing clinical trials trial information Safety, Side Effects & Provider Use Retatrutide Dosing: Early Clinical Trial – People always say my dose

Samples were processed for histology

Do not touch the eye with the applicator

It works by: Slowing gastric emptying , which prolongs feelings of fullness after eating Reducing appetite through effects on brain regions that regulate hunger Improving glycaemic control by enhancing insulin secretion when blood glucose is elevated Reducing glucagon secretion , which helps prevent excessive glucose production by the liver The medication is administered as a once-weekly subcutaneous injection, with doses gradually increased over 16-20 weeks to the maintenance dose of 2.4 mg weekly (though some patients may remain on 1.7 mg if the higher dose is not tolerated)

Please be aware that applying does not mean the medication will be shipped immediately